The highly anticipated trial between Canary Wharf Group and the European Medicines Agency – over whether Brexit “frustrates” the EMA’s lease, allowing it to walk away from its £13m-a-year obligations, has reached court.
Here, EG’s deputy legal and professional editor, Jess Harrold, talks you through the key arguments put forward by both sides and explains how the legal doctrine of frustration works.